TCL Archive Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials July 11, 2003
TCL Archive Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement October 28, 2011
TCL Archive Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal December 16, 2011
